Berahyaluronidase alfa is a recombinant human hyaluronidase that temporarily increases tissue permeability by degrading hyaluronan in the extracellular matrix, thereby facilitating the absorption and dispersion of co-administered subcutaneous drugs like pembrolizumab.
Purity:
95.00%
CAS Number:
[2636716-20-4]
Target:
glycosidase
* VAT and and shipping costs not included. Errors and price changes excepted
